220688-25-5

Upstream product

• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 171032-74-9 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-D-glucopyranose 
• 929040-77-7 4-methylphenyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-thio-α,β-D-glucopyranoside 
• 545-06-2 trichloroacetonitrile 
• 201015-97-6 phenyl 2-azido-3,4,6-tri-O-benzyl-2-deoxy-1-thio-α/β-D-glucopyranoside 
• 183875-22-1 phenyl 2-azido-2-deoxy-3,4,6-tri-O-acetyl-1-thio-α/β-D-glucopyranoside 
• 202462-37-1 phenyl 2-azido-2-deoxy-1-thio-α/β-D-glucopyranoside 

Downstream Products

• 627886-43-5 2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-glucopyranosyl-α-(1->2)-3,4,5,6-tetra-O-benzyl-D-chiro-inositol 
• 944064-87-3 O-(2-azido-2-deoxy-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)(1->3)-6-O-(triisopropylsilyl)-D-galactal 
• 944064-93-1 O-(2-azido-2-deoxy-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(1->6)-3,4-di-O-benzyl-D-galactal 
• 944064-74-8 O-(2-O-azido-3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyl)-(1->6)-[O-(2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl)-(1->3)]-4-O-benzyl-D-galactal 
• 1035456-87-1 2-azido-3,4,6-tri-O-benzyl-2-deoxy-D-α-glucopyranosyI-(1-6)-3,4,5-tri-O-benzyl-1,2-didehydro-1,2-dideoxy-D-myo-inositol 
• 1035456-76-8 N-(2-azido-3,4,6-tri-O-benzyl-1,2-dideoxy-α-D-glucopyranosyl)trichloroacetamide 
• 1035456-77-9 2-azido-3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyI-(1-6)-3,4,5-tri-O-benzyl-D-myo-inositol-1,2-cyclic carbonate 
• 1035456-73-5 2-azido-3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyI-(1-6)-3,4,5-tri-O-benzyl-D-myo-inositol-1,2-cyclic carbonate 
• 1448023-34-4 C₅₀H₇₂N₄O₇ 
• 1463473-26-8 C₅₀H₇₂N₄O₇ 

Relevant academic research and scientific papers

Synthesis and anti-influenza a virus activity of 6′-amino-6′-deoxy-glucoglycerolipids analogs

A series of aminoglucoglycerolipids derivatives had been synthesized, including 6′-acylamido-glucoglycerolipids 1a-1f and corresponding 2′-acylamido-glucoglycerolipids 2a-2c bearing different fatty acids, glucosyl diglycerides 3a-3e bearing different func

Glycosyl inositol derivatives related to inositolphosphoglycan mediators: Synthesis, structure, and biological activity

Some biologically active structures related to inositolphosphoglycan (IPG) mediators (compounds 3-5) and the corresponding glycosylphosphatidylinositol precursors (compounds 1 and 2) have been prepared by using an effective synthetic strategy. The basic s